Format

Send to

Choose Destination
Haematologica. 2014 Jun;99(6):945-9. doi: 10.3324/haematol.2014.106013.

Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials.

Author information

1
Hematology and Oncology Section, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY john.mascarenhas@mssm.edu.
2
Division of Hematology and Medical Oncology, Mayo Clinic Scottsdale, AZ.
3
Pathology, and Genetics, Division of Hematology, University of Utah School of Medicine, UT, USA.
4
Hematology and Oncology Section, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY.
PMID:
24881037
PMCID:
PMC4040888
DOI:
10.3324/haematol.2014.106013
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center